Author Information (click to view)
Physician's Weekly
Physician's Weekly (click to view)
Physician’s Weekly, along with Yehuda Handelsman, MD, hosted a live Tweet Chat on Thursday, April 27. This discussion focused on lipid management in patients with diabetes & heart disease. Dr. Handelsman is the current medical director of the Metabolic Institute of America, and is a former president of American Association of Clinical Endocrinologists.
Below is a recap of the discussion.
You can see the full transcript on Twitter here.
Question 1
@physicianswkly A1: High TGL, low HDL elevated- not very high- LDL made of small dense particles caused by insulin resistance #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 2
@physicianswkly A2: Typically requires multiple medications for good control which increases cost, is a burden to the patients and reduce adherence #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 3
@physicianswkly A3: Not much difference, both need statins generally, high potency however Pts w/ diabetes may need more meds, ie to control TGL #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 4
@physicianswkly A4: Whether Pts w/DM are CAD equivalent & need to be treated as aggressive as people with no DM? #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 5
@physicianswkly A5: High potency statins, often in combination with zetia, at times need PCSK9i, omega 3 Fish oil and or fibrates #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Previous Physician’s Weekly #PWChats
- What Is the Future of Healthcare Under President Trump?
- What the Future of Healthcare Will Look Like Under Pres. Trump (Part II)
Question 6
@physicianswkly A6: These PTs based on AACE Lipid GLs have Extreme risk need LDL goal <55 that’s hard to reach, need combo meds w/ statins & PCSK9i #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 7
@physicianswkly A7: Combination medications, target non-HDL goal, addressing LDL & TGL and PCSK9i & EPA fish oil less fibrates less niacin #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 8
@physicianswkly @TheAACE A8: Pts w/established CVD who have DM, CKD, HeFH or those with recurrent events despite LDL < 70 #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 9
@physicianswkly A9: LDL < 55 and/or Non HDL < 80 and/or Apo B < 70
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 10
@physicianswkly A10: Courses & Live conferences like the Heart in Diabetes on 7/14-16/17 Sheraton Downtown Philadelphia https://t.co/Oq8LV5WmAH #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
Question 11
@physicianswkly A11: In past 2-3 yrs several trials underscored connection of DM & CVD, creating need to assess their impact on clinical practice #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017
@physicianswkly A11:Need to have cardiologists endocrinologists & nephrologist in 1 place to examine, understand &work together to teach the outcome #PWChat
— Yehuda Handelsman (@yhandelsmanmd) April 28, 2017